- $211.1 million of series 2014A fixed rate bonds
- $67.7 million of series 2008A fixed rate bonds
The rating affirmation is based on a number of factors, including WellSpan’s expanding regional presence and solid profitability.
The outlook is stable.
More articles on healthcare finance:
Erlanger’s income exceeds budget on higher admissions
Dignity Health plans 4 neighborhood hospitals in Las Vegas area: 5 things to know
6 findings on Alaska’s Medicaid expansion: Progress and potential redesign
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit